This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hai, R.
Right arrow Articles by Palese, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hai, R.
Right arrow Articles by Palese, P.

 Previous Article  |  Next Article 

Journal of Virology, November 2008, p. 10580-10590, Vol. 82, No. 21
0022-538X/08/$08.00+0     doi:10.1128/JVI.01213-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Influenza B Virus NS1-Truncated Mutants: Live-Attenuated Vaccine Approach{triangledown}

Rong Hai,1 Luis Martínez-Sobrido,1,3 Kathryn A. Fraser,1 Juan Ayllon,4 Adolfo García-Sastre,1,2,3 and Peter Palese1,2*

Departments of Microbiology,1 Medicine,2 Emerging Pathogens Institute, Mount Sinai School of Medicine, New York, New York 10029,3 Departamento de Bioquímica y Biología Molecular, Universidad de Salamanca, Salamanca, Spain4

Received 11 June 2008/ Accepted 22 August 2008

Type B influenza viruses can cause substantial morbidity and mortality in the population, and vaccination remains by far the best means of protection against infections with these viruses. Here, we report the construction of mutant influenza B viruses for potential use as improved live-virus vaccine candidates. Employing reverse genetics, we altered the NS1 gene, which encodes a type I interferon (IFN) antagonist. The resulting NS1 mutant viruses induced IFN and, as a consequence, were found to be attenuated in vitro and in vivo. The absence of pathogenicity of the NS1 mutants in both BALB/c and C57BL/6 PKR–/– mice was confirmed. We also provide evidence that influenza B virus NS1 mutants induce a self-adjuvanted immune response and confer effective protection against challenge with both homologous and heterologous B virus strains in mice.

* Corresponding author. Mailing address: Department of Microbiology, Mount Sinai School of Medicine, Box 1124, One Gustave L. Levy Place, New York, NY 10029. Phone: (212) 241-7318. Fax: (212) 534-1684. E-mail: peter.palese{at}mssm.edu

{triangledown} Published ahead of print on 3 September 2008.

Journal of Virology, November 2008, p. 10580-10590, Vol. 82, No. 21
0022-538X/08/$08.00+0     doi:10.1128/JVI.01213-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Lowen, A. C., Steel, J., Mubareka, S., Carnero, E., Garcia-Sastre, A., Palese, P. (2009). Blocking Interhost Transmission of Influenza Virus by Vaccination in the Guinea Pig Model. J. Virol. 83: 2803-2818 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»